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Antibody Response to Melanoma Cell Vaccine Correlates with Survival
Effective vaccines for cancer are wanted by everyone, and significant
progress has been made in developing vaccines to melanoma. The
question is which antigens generate the most effective vaccines? Anti-
tumor activity of antibodies to gangliosides has been demonstrated in
both laboratory and early clinical trials; however, the effects of vaccine
therapy on long-term survival are not known. In a retrospective study
(p. 205) Takahashi et al demonstrate that IgM to gangliosides are
induced by a melanoma cell vaccine (MCV), and find a positive
correlation between antibody levels and survival of patients with
melanoma. The MCV contains four related gangliosides from three
An Understanding of Variants Epidermolysis Bullosa Simplex
Definition of disease at the molecular level has caused investigators to
believe there is a direct link between genotype and phenotype.
Epidermolysis bullosa simplex (EBS) is an autosomal dominant disease
caused by mutations in either the keratin 5 (K5) or the keratin 14
(K14) gene. There are three major subtypes: Weber-Cockayne (EBS-
WC), Koebner (EBS-K), and Dowling-Meara (EBS-DM).
Sorensen et al (p. 184) have used EBS to correlate the genotype
with the phenotype. Mutations in keratins 5 and 14 were studied in
five EBS Danish families. Three of the five families may have been
related and had clinical signs consistent with EBS-WC; they had the
Bullous Pemphigoid Sera Recognizes Both Intracellular and Extracellular Antigens
Much has been learned of the nature of antigens of bullous pemphigoid
(BP). Patients with BP have antibodies directed against two antigens;
an intracellular protein (BPAg1) and a trans-cellular protein (BPAg2).
To gain further insight Perriard et al (p. 141) have constructed
recombinant proteins containing portions of intracellular and extracellu-
lar domains of BPAg2 in a COS-7 cell line, which generates post-
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human melanoma cell lines. Sera that had been collected prior to and
4 wk post-therapy were analyzed from 66 patients who had received
MCV after surgery for metastatic melanoma.
Patients were grouped according to their survival. Analysis showed
that antibody levels were elevated by week 4 of therapy, with the
strongest response to GM2 and GM3 gangliosides. Importantly, these
investigators were able to show that antibodies to all four gangliosides
were significantly higher in the 5 y survival group than in the
other groups.
same heterozygous base substitution in the gene of K14. The other
two families had a different mutation and different phenotypes. These
results support the overall impression that minor, conservative amino
acid changes result in mild disease, whereas major change results in a
more severe clinical phenotype.
This study has expanded our understanding of reasons behind the
variants of the same disease (mild to severe) as well as the functional
domains of keratin. The finding of different mutations in different
families with EBS precludes the use of these molecular methods as a
general genetic screening tool, but they can be used within a family.
translational modifications. They show that the majority of BP sera
react with a short stretch of the extracellular domain of BPAg2 close
to the cell membrane, the NC16A domain. They also find that some
BP sera recognize extracellular epitopes that are more distant from the
cell membrane. Over half of the sera tested contain antibodies that
react with epitopes contained in the intracellular region of BPAg2.
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Furthermore, antibodies recognizing epitopes in the extracellular
domain do not cross-react with the intracellular epitopes.
These findings demonstrate that BP sera recognize multiple epitopes
on BPAg2. This is supported by the findings of Egan et al (p. 148),
who report BP sera containing IgG antibodies to BPAg2 cross-react
with another portion of BPAg2, the 97 kDa linear IgA antigen.
The presence of antibodies directed against intracellular epitopes is
Staphylococcal Toxin may Cause Allergy in Atopic Patients
Superantigens have given rise to a clinical question, ‘‘do infections play
a role in the increased levels of allergen specific IgE?’’ The etiology of
IgE mediated allergy is multifactorial. The report by Hofer et al (p.
171) explores the possibility that allergic diseases may be modulated
by a staphylococcal superantigen (toxic shock syndrome toxin-1,
TSST-1).
Previously they noted that IgE production by peripheral blood
mononuclear cells (PBMC) from atopics is elevated in vitro by TSST-
1, and that TSST-1 appears to induce its effect by bridging between
the T cell receptor on TH2-type T cells with class II MHC antigens
on B cells. In this study, patients with asthma or rhinitis secondary to
grass and/or pollen were studied during and outside of the pollen
interesting, the next question is how antibody responses to intracellular
epitopes occur. Is it epitope spreading or does an immune response
against extracellular epitopes lead to a compromise of keratinocyte
integrity and a secondary immune response. If either is the case, it
could be that the secondary immune response is the element the leads
to extension and perpetuation of disease.
season. PBMC from subjects with allergen exposure during the pollen
season had enhanced IgE production when stimulated with TSST-1
and had significantly decreased interferon gamma production, a cytokine
known to inhibit IgE synthesis. Furthermore, they showed that among
symptomatic nonatopic patients with cat allergies, PBMC stimulated
with TSST-1 led to allergen-specific IgE production. TSST-1 was also
found to upregulate B7.2, a member of the B7 family expressed on
antigen-presenting cells known to enhance TH2 activation in mice.
This study adds grist to the mill for those who feel that microbes
are important modulators of our immune response to the environment.
Carefully controlled clinical trials could provide the necessary support-
ive data.
